A Response To:  Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Source: Diabetes Therapy - Category: Endocrinology Source Type: research